BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ademe M. Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges. Front Cell Infect Microbiol 2020;10:469. [PMID: 33042859 DOI: 10.3389/fcimb.2020.00469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Burgess TB, Condliffe AM, Elks PM. A Fun-Guide to Innate Immune Responses to Fungal Infections. JoF 2022;8:805. [DOI: 10.3390/jof8080805] [Reference Citation Analysis]
2 Prathapan P. A determination of pan-pathogen antimicrobials? Medicine in Drug Discovery 2022. [DOI: 10.1016/j.medidd.2022.100120] [Reference Citation Analysis]
3 Boniche-Alfaro C, Kischkel B, Thomaz L, Carvalho-Gomes MM, Lopes-Bezerra LM, Nosanchuk JD, Taborda CP. Antibody- Based Immunotherapy Combined With Antimycotic Drug TMP- SMX to Treat Infection With Paracoccidioides brasiliensis. Front Immunol 2021;12:725882. [PMID: 34737741 DOI: 10.3389/fimmu.2021.725882] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Sahu RK, Salem-Bekhit MM, Bhattacharjee B, Almoshari Y, Ikbal AMA, Alshamrani M, Bharali A, Salawi A, Widyowati R, Alshammari A, Elbagory I. Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies. Antibiotics (Basel) 2021;10:1079. [PMID: 34572661 DOI: 10.3390/antibiotics10091079] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
5 Shah SB. COVID-19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use. Endocr Metab Sci 2021;:100110. [PMID: 34396354 DOI: 10.1016/j.endmts.2021.100110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]